Rohit R. Arora

Nesiritide: Trials and Tribulations
J Cardiovasc Pharmacol Ther 2006 11: 165-169. [Abstract] [PDF] [References]  

Charles H. Hennekens, Oksana Sechenova, Danielle Hollar, and Victor L. Serebruany

Dose of Aspirin in the Treatment and Prevention of Cardiovascular Disease: Current and Future Directions
J Cardiovasc Pharmacol Ther 2006 11: 170-176. [Abstract] [PDF] [References]  

Arnfinn Ilebekk, Morten Eriksen, Knut Sevre, Trude Aspelin, Jan-Arne Björkman, Torstein Lyberg, and Margareta Nordlander

Ventricular Fibrillation Induced by Ischemia-Reperfusion Is Not Prevented by the NPY Y2 Receptor Antagonist BIIE0246
J Cardiovasc Pharmacol Ther 2006 11: 177-183. [Abstract] [PDF] [References]  

Nitin Wadhani, Jonnalagedda SM Sarma, Bramah N. Singh, David Radzik, and Christine Gaud

Dose-Dependent Effects of Oral Dronedarone on the Circadian Variation of RR and QT Intervals in Healthy Subjects: Implications for Antiarrhythmic Actions
J Cardiovasc Pharmacol Ther 2006 11: 184-190. [Abstract] [PDF] [References]  

Victor Serebruany, Alex Malinin, and Robert Scott

The In Vitro Effects of a Novel Vascular Protectant, AGI-1067, on Platelet Aggregation and Major Receptor Expression in Subjects With Multiple Risk Factors for Vascular Disease
J Cardiovasc Pharmacol Ther 2006 11: 191-196. [Abstract] [PDF] [References]  

Fahed Bitar, Amir Lerman, Mohammed W. Akhter, Parta Hatamizadeh, Munir Janmohamed, Salman Khan, and Uri Elkayam

Variable Response of Conductance and Resistance Coronary Arteries to Endothelial Stimulation in Patients With Heart Failure Due to Nonischemic Dilated Cardiomyopathy
J Cardiovasc Pharmacol Ther 2006 11: 197-202. [Abstract] [PDF] [References]  

Suzan M.G.A. El-Ghar, Mabood Qureshi, Ahmed Shoker, and Kailash Prasad

Oxidative Stress in Renal Transplant Patients Who Develop Cardiovascular Disease
J Cardiovasc Pharmacol Ther 2006 11: 203-210. [Abstract] [PDF] [References]  

Dimitrios S. Christidis, Evangelos N. Liberopoulos, Anna I. Kakafika, George A. Miltiadous, Marios Cariolou, Emmanuel S. Ganotakis, Dimitri P. Mikhailidis, and Moses S. Elisaf

The Effect of Apolipoprotein E Polymorphism on the Response to Lipid-Lowering Treatment With Atorvastatin or Fenofibrate
J Cardiovasc Pharmacol Ther 2006 11: 211-221. [Abstract] [PDF] [References]  

To see an article, click its [PDF] link. To add articles to your marked citations, check the boxes to the left of the titles you want, and click the 'Add to Marked Citations' button. To see one abstract at a time, click its [Abstract] link.